Global Vials for COVID-19 Vaccine 麻豆原创 Research Report 2024

Publication ID:

PB503240891

Publication Date:

March 11, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Packaging [2]

Industry & Manufacturing [3]

Description:

The global Vials for COVID-19 Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vials for COVID-19 Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vials for COVID-19 Vaccine.
Report Scope
The Vials for COVID-19 Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vials for COVID-19 Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vials for COVID-19 Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Corning
Schott AG
SiO2 Materials Science
SGD Pharma
Stevanato Group
DWK Life Sciences
Gerresheimer
Segment by Type
Middle-borate Borosilicate Glass
Low-borate Borosilicate Glass
Segment by Application
Vaccine Manufacturing
Vaccine Researching
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vials for COVID-19 Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vials for COVID-19 Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Vials for COVID-19 Vaccine 麻豆原创 Overview
1.1 Product Overview and Scope of Vials for COVID-19 Vaccine
1.2 Vials for COVID-19 Vaccine Segment by Type
1.2.1 Global Vials for COVID-19 Vaccine 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Middle-borate Borosilicate Glass
1.2.3 Low-borate Borosilicate Glass
1.3 Vials for COVID-19 Vaccine Segment by Application
1.3.1 Global Vials for COVID-19 Vaccine 麻豆原创 Value by Application: (2024-2030)
1.3.2 Vaccine Manufacturing
1.3.3 Vaccine Researching
1.4 Global Vials for COVID-19 Vaccine 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Vials for COVID-19 Vaccine Revenue 2019-2030
1.4.2 Global Vials for COVID-19 Vaccine Sales 2019-2030
1.4.3 Global Vials for COVID-19 Vaccine 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vials for COVID-19 Vaccine 麻豆原创 Competition by Manufacturers
2.1 Global Vials for COVID-19 Vaccine Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Vials for COVID-19 Vaccine Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Vials for COVID-19 Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Vials for COVID-19 Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vials for COVID-19 Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vials for COVID-19 Vaccine, Product Type & Application
2.7 Vials for COVID-19 Vaccine 麻豆原创 Competitive Situation and Trends
2.7.1 Vials for COVID-19 Vaccine 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vials for COVID-19 Vaccine Players 麻豆原创 Share by Revenue
2.7.3 Global Vials for COVID-19 Vaccine 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vials for COVID-19 Vaccine Retrospective 麻豆原创 Scenario by Region
3.1 Global Vials for COVID-19 Vaccine 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vials for COVID-19 Vaccine Global Vials for COVID-19 Vaccine Sales by Region: 2019-2030
3.2.1 Global Vials for COVID-19 Vaccine Sales by Region: 2019-2024
3.2.2 Global Vials for COVID-19 Vaccine Sales by Region: 2025-2030
3.3 Global Vials for COVID-19 Vaccine Global Vials for COVID-19 Vaccine Revenue by Region: 2019-2030
3.3.1 Global Vials for COVID-19 Vaccine Revenue by Region: 2019-2024
3.3.2 Global Vials for COVID-19 Vaccine Revenue by Region: 2025-2030
3.4 North America Vials for COVID-19 Vaccine 麻豆原创 Facts & Figures by Country
3.4.1 North America Vials for COVID-19 Vaccine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.4.3 North America Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vials for COVID-19 Vaccine 麻豆原创 Facts & Figures by Country
3.5.1 Europe Vials for COVID-19 Vaccine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.5.3 Europe Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vials for COVID-19 Vaccine 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Vials for COVID-19 Vaccine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vials for COVID-19 Vaccine 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Vials for COVID-19 Vaccine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vials for COVID-19 Vaccine 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Vials for COVID-19 Vaccine 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vials for COVID-19 Vaccine Sales by Type (2019-2030)
4.1.1 Global Vials for COVID-19 Vaccine Sales by Type (2019-2024)
4.1.2 Global Vials for COVID-19 Vaccine Sales by Type (2025-2030)
4.1.3 Global Vials for COVID-19 Vaccine Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Vials for COVID-19 Vaccine Revenue by Type (2019-2030)
4.2.1 Global Vials for COVID-19 Vaccine Revenue by Type (2019-2024)
4.2.2 Global Vials for COVID-19 Vaccine Revenue by Type (2025-2030)
4.2.3 Global Vials for COVID-19 Vaccine Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Vials for COVID-19 Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vials for COVID-19 Vaccine Sales by Application (2019-2030)
5.1.1 Global Vials for COVID-19 Vaccine Sales by Application (2019-2024)
5.1.2 Global Vials for COVID-19 Vaccine Sales by Application (2025-2030)
5.1.3 Global Vials for COVID-19 Vaccine Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Vials for COVID-19 Vaccine Revenue by Application (2019-2030)
5.2.1 Global Vials for COVID-19 Vaccine Revenue by Application (2019-2024)
5.2.2 Global Vials for COVID-19 Vaccine Revenue by Application (2025-2030)
5.2.3 Global Vials for COVID-19 Vaccine Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Vials for COVID-19 Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Corning
6.1.1 Corning Corporation Information
6.1.2 Corning Description and Business Overview
6.1.3 Corning Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Corning Vials for COVID-19 Vaccine Product Portfolio
6.1.5 Corning Recent Developments/Updates
6.2 Schott AG
6.2.1 Schott AG Corporation Information
6.2.2 Schott AG Description and Business Overview
6.2.3 Schott AG Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Schott AG Vials for COVID-19 Vaccine Product Portfolio
6.2.5 Schott AG Recent Developments/Updates
6.3 SiO2 Materials Science
6.3.1 SiO2 Materials Science Corporation Information
6.3.2 SiO2 Materials Science Description and Business Overview
6.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SiO2 Materials Science Vials for COVID-19 Vaccine Product Portfolio
6.3.5 SiO2 Materials Science Recent Developments/Updates
6.4 SGD Pharma
6.4.1 SGD Pharma Corporation Information
6.4.2 SGD Pharma Description and Business Overview
6.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SGD Pharma Vials for COVID-19 Vaccine Product Portfolio
6.4.5 SGD Pharma Recent Developments/Updates
6.5 Stevanato Group
6.5.1 Stevanato Group Corporation Information
6.5.2 Stevanato Group Description and Business Overview
6.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Stevanato Group Vials for COVID-19 Vaccine Product Portfolio
6.5.5 Stevanato Group Recent Developments/Updates
6.6 DWK Life Sciences
6.6.1 DWK Life Sciences Corporation Information
6.6.2 DWK Life Sciences Description and Business Overview
6.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 DWK Life Sciences Vials for COVID-19 Vaccine Product Portfolio
6.6.5 DWK Life Sciences Recent Developments/Updates
6.7 Gerresheimer
6.6.1 Gerresheimer Corporation Information
6.6.2 Gerresheimer Description and Business Overview
6.6.3 Gerresheimer Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gerresheimer Vials for COVID-19 Vaccine Product Portfolio
6.7.5 Gerresheimer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vials for COVID-19 Vaccine Industry Chain Analysis
7.2 Vials for COVID-19 Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vials for COVID-19 Vaccine Production Mode & Process
7.4 Vials for COVID-19 Vaccine Sales and 麻豆原创ing
7.4.1 Vials for COVID-19 Vaccine Sales Channels
7.4.2 Vials for COVID-19 Vaccine Distributors
7.5 Vials for COVID-19 Vaccine Customers
8 Vials for COVID-19 Vaccine 麻豆原创 Dynamics
8.1 Vials for COVID-19 Vaccine Industry Trends
8.2 Vials for COVID-19 Vaccine 麻豆原创 Drivers
8.3 Vials for COVID-19 Vaccine 麻豆原创 Challenges
8.4 Vials for COVID-19 Vaccine 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Corning
Schott AG
SiO2 Materials Science
SGD Pharma
Stevanato Group
DWK Life Sciences
Gerresheimer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.